Search Within

Hong Zhang

Formats
  1. Meeting Abstract (28)
  2. Journal Article (24)
  3. Miscellaneous (1)
  4. Review (1)
Groups
  1. Department of Pathology and Laboratory Medicine (54)
  2. Sloan Kettering Institute Postdocs (30)
  3. GSK Faculty (29)
  4. GDMT, Pathology and Laboratory Medicine (26)
  5. Gynecology Disease Management Team (26)
  6. Breast Medicine Service (18)

More Groups

People
  1. Edi Brogi (29)
  2. Hannah Wen (29)
  3. Fresia Pareja Zea (27)
  4. Jorge Reis-Filho (27)
  5. Britta Weigelt (26)
  6. Edaise Da Silva (21)

More People

Years
  1. 2025 (2)
  2. 2024 (9)
  3. 2023 (4)
  4. 2022 (13)
  5. 2021 (8)
  6. 2020 (11)

More Years

Publications
  1. Laboratory Investigation (15)
  2. Cancer Research (6)
  3. npj Breast Cancer (5)
  4. Annals of Oncology (4)
  5. Modern Pathology (4)
  6. Annals of Surgical Oncology (2)

More Publications

Publishers
  1. Nature Publishing Group (20)
  2. American Association for Cancer Research (7)
  3. Nature Research (4)
  4. Oxford University Press (4)
  5. BMJ Publishing Group Ltd. (2)
  6. College of American Pathologists (2)

More Publishers

Results (54)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • KIT genetic alterations in breast cancer
    Journal Article

    Vahdatinia, M.; Derakhshan, F.; Da Cruz Paula, A.; Dopeso, H.; Marra, A.; Gazzo, A. M.; Brown, D.; Selenica, P.; Ross, D. S.; Razavi, P.; more...
    Journal of Clinical Pathology (2024)

    Fulltext@MSK | Save
  • Atezolizumab (atezo) and tumour microenvironment in early triple-negative breast cancer (eTNBC): Exploratory biomarker analysis from IMpassion031
    Meeting Abstract

    Harbeck, N.; Duan, C.; DuPree, K.; Chang, C. W.; Barrios, C. H.; Zhang, H. A.; Saji, S.; Jung, K. H.; Telli, M. L.; Liste Hermoso, M.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Whole-genome sequencing analysis of invasive lobular carcinomas lacking CDH1 alterations
    Meeting Abstract

    Dopeso, H.; Selenica, P.; Derakhshan, F.; Da Cruz Paula, A.; Marra, A.; da Silva, E. M.; Basili, T.; Gazzo, A.; Bhaloo, S.; Oesterreich, S.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • The histologic and genomic features of breast cancers harboring genetic alterations in RecQ DNA helicases
    Meeting Abstract

    Kaur, G.; Selenica, P.; Gazzo, A.; Cartagena, L. C.; Daaboul, F.; Dopeso, H.; da Silva, E. M.; Ross, D.; Zhang, H.; Wen, H.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Breast cancers harboring FANCA genetic alterations
    Meeting Abstract

    Cartagena, L. C.; Marra, A.; Brown, D.; Gazzo, A.; Selenica, P.; Dopeso, H.; da Silva, E. M.; Kaur, G.; Ross, D.; Zhang, H.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Prediction of neoadjuvant treatment outcomes with multimodal data integration in breast cancer
    Meeting Abstract

    Khosravi, P.; Sutton, E. J.; Jee, J.; Dalfonso, T.; Fong, C. J.; Rose, D.; Da Silva, E. M.; Kohli, A.; Ho, D. J.; Ahmed, M. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Patient-reported outcomes from a randomized trial of neoadjuvant atezolizumab-chemotherapy in early triple-negative breast cancer
    Journal Article

    Barrios, C. H.; Saji, S.; Harbeck, N.; Zhang, H.; Jung, K. H.; Patel, S.; Patel, S.; Duc, A. N.; Liste-Hermoso, M.; Chui, S. Y.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • Atezolizumab with neoadjuvant anti-human epidermal growth factor receptor 2 therapy and chemotherapy in human epidermal growth factor receptor 2-positive early breast cancer: Primary results of the randomized phase III IMpassion050 trial
    Journal Article

    Huober, J.; Barrios, C. H.; Niikura, N.; Jarząb, M.; Chang, Y. C.; Huggins-Puhalla, S. L.; Pedrini, J.; Zhukova, L.; Graupner, V.; Eiger, D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Solid-basaloid variant of adenoid cystic carcinoma of the breast with near complete response to neoadjuvant chemotherapy
    Journal Article

    Grabenstetter, A.; Brogi, E.; Zhang, H.; Razavi, P.; Reis-Filho, J. S.; VanZee, K. J.; Norton, L.; Wen, H. Y.
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • Updates on lobular neoplasms and papillary, adenomyoepithelial, and fibroepithelial lesions of the breast
    Review

    Li, X.; Febres-Aldana, C.; Zhang, H.; Zhang, X.; Uraizee, I.; Tang, P.
    Archives of Pathology & Laboratory Medicine (2022)

    Fulltext@MSK | Save